Plain-English translation of NCT07027124 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Read our Prostate Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
United States
Phase
Testing effectiveness
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
Merck Sharp & Dohme LLC, Bayer
Enrollment target
~40 participants
Started
May 2026
Primary completion
December 2027
Age range
18 Years and older
Sex
Male only
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Daniela Delbeau- Zagelbaum, RN, NP
Icahn School of Medicine at Mount Sinai
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.